HeXun Biosciences, Corp. (HeXun), founded by President Frank Wen in June 2019, is the first Regenerative Medicinal company accredited the “Accelerated Investment Program for Small and Medium Enterprises ”by Taiwan Ministry of Economic Affairs in 2020. We were also honored to be awarded “The Excellent Enterprise Award of Taoyuan City ”in 2021. HeXun has established a cell factory for regenerative medicinal products development. And aim to develop effective regenerative medicinal product for cardiovascular diseases. In addition to substantiating the development of our Umbilical Cord Mesenchymal Stem Cell products, a more effective and potent second and third generation cell therapy products are under research and development.